Learn More Our Grants Fund
and HOPE
Our Mission
Learn More Your Gift
Will Fund
Breakthroughs In
Lung Cancer Research
Learn More Join Us
And Help
Find A Cure for
Lung Cancer
Get Involved
Learn More Prelude Funded
Is Already
Making an Impact

Passion. Purpose. Progress. In that order.


From the desk of Ros Miller

We have the solution!  Join the Prelude team because our solution is fun, different, easy, not expensive and you’ll feel good joining.  Make a small donation of $10 and then pick up a set of knitting needles or a crochet hook and some yarn and purposefully, intentionally make something with love that will…

Continue Reading
Dr RObinson and Board Member celebrating his knitting

Why we give

Lung cancer doesn’t care. It doesn’t care who you are, what you do, where you live, how you live, even if you smoked. Lung cancer just doesn’t care.  I care!      We care!      You can too! The Prelude to a Cure Board at our Recent Knit-A-Lung Fundraiser. Anyone can get lung cancer….

Continue Reading

Join Our Knit-A-Lung!

If you don’t knit, we can teach you or hook you up with a teacher. Why is a cancer research charity involved in knitting? It turns out that the knitting and fiber arts community are driven by Passion, Purpose and Progress, sharing the same way we feel about finding a cure for cancer. Not long…

Continue Reading

Welcome to the New Prelude to a Cure

2020 is in the rearview mirror as the year no one was prepared for. During COVID, Prelude to a Cure (Prelude/P2AC) found itself at odds with our mission and goal with the need to be safe and socially distant from each other. Though, we were not idle. The Board of Prelude took a look at ourselves…

Continue Reading

Prelude to a Cure Shines a Light on Cancer Research

Meet Dr. Boyle Dr. Theresa Boyle is a pathologist – a self-described doctor’s doctor.  Her role is to analyze and interpret biopsied tissue samples for thoracic oncologists and surgeons to develop patient treatment plans. Her career at Moffitt Cancer Center began two and a half years ago and she divides her efforts between the Thoracic and…

Continue Reading

Mourning a Cancer Hero – Dr. Charles WIlliams

<This tribute was written by Prelude Founder and friend of Dr. Williams, Dr. Lary Robinson> March 28, 2018 marked the end of an era at Moffitt Cancer Center with the passing of thoracic oncologist, Dr. Charles Williams. On his drive to his busy clinic that morning to see lung cancer patients, a speeder ran a…

Continue Reading

Our Twitter feed

According to a recent study published in the Journal of Thoracic Oncology, cystisine may be a safe and effective smoking cessation treatment in lung cancer screening volunteers. https://t.co/dxLpJM8qwV
Two new studies unveiled last month at a conference in Paris, France showed advanced lung cancer patients have a better chance of survival when their chemotherapy is paired with a drug that is designed to turn the body’s immune system against cancer. https://t.co/fjwyiZgoBl
Alison Todd, 47, developed a cough during the 2020 Christmas season, chalking it up to a symptom of “long COVID,” before finding out months later that she actually had advanced-stage lung cancer. https://t.co/3ffO2iwaZ9
Currently, 1 in 16 people in the U.S. can expect to receive a lung cancer diagnosis. That’s 1 out of every 15 men, and 1 out of every 17 women. That's why your support of innovative lung cancer research matters. Visit https://t.co/HZ4pzrt33S to learn more. https://t.co/7iBoyHyuM1 PreludetoaCure1 photo
Dr. Bradford Perez, Dr. Teresa Boyle, and Dr. Ben Creelan were the first recipients of our seed grant funding to find innovative ways to fight lunch cancer. Read about their grants and learn how these amazing research physicians are fighting lung cancer at https://t.co/T1AlFNoBOl https://t.co/WLVEFdvYVe PreludetoaCure1 photo
After months of antibiotics for a sinus infection Kai didn’t have, weeks of headaches, coughing and low-grade fevers, a referral to an ENT specialist and prescribed treatments, the doctor sent him for a last-ditch X-ray. They found the mass in his lung. https://t.co/3Cqn8mYDt6